eXoZymes, Inc. (EXOZ)

eXoZymes Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2022
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Net Income	-8.34	-5.86	-2.04	-1.4	-1.21
Depreciation & Amortization	0.28	0.27	0.2	0.15	0.06
Stock-Based Compensation	1.63	1.13	0.28	0.22	0.2
Other Adjustments	0	-0.02	0.16	-0.04	-0.1
Changes in Accounts Payable	0.28	0.22	0.27	-	-
Changes in Income Taxes Payable	-	-0.04	-0.02	0.06	-
Changes in Other Operating Activities	-3.97	-4.2	-0.03	-0.25	-0.54
Operating Cash Flow	-10.24	-8.51	-1.18	-1.26	-1.59
Capital Expenditures	-0.31	-0.4	-0.29	-0.19	-0.42
Other Investing Activities	0.02	0.04	-0.02	0.1	0.11
Investing Cash Flow	-0.29	-0.36	-0.31	-0.09	-0.31
Issuance of Common Stock	-	14.54	-	1.36	2.31
Net Common Stock Issued (Repurchased)	-	14.54	-	1.36	2.31
Other Financing Activities	0.75	3.98	1	-	-
Financing Cash Flow	7.95	18.52	1	1.36	2.31
Net Cash Flow	4.86	9.65	-0.49	0.01	0.41
Free Cash Flow	-10.54	-8.9	-1.47	-1.44	-2.01
FCF Margin	-	-	-2097.34%	-5046.08%	-
Free Cash Flow Per Share	-1.29	-1.36	-0.24	-0.24	-0.39
Levered Free Cash Flow	-12.05	-10.01	-1.91	-1.62	-2.11
Unlevered Free Cash Flow	-12.72	-10.08	-1.71	-1.5	-2.19

Updated Sep 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q